The Lancet Neurology in conversation with
Een podcast door The Lancet Group - Donderdagen
187 Afleveringen
-
William Jagust on amyloid β and cognition
Gepubliceerd: 16-8-2023 -
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
Gepubliceerd: 19-7-2023 -
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
Gepubliceerd: 21-6-2023 -
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
Gepubliceerd: 18-5-2023 -
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
Gepubliceerd: 13-4-2023 -
Kerstin Hellwig on family planning considerations in MS
Gepubliceerd: 15-3-2023 -
Geraldine Dawson on advances in the prediction of autism during infancy
Gepubliceerd: 16-2-2023 -
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
Gepubliceerd: 19-1-2023 -
Beau Ances on amyloid biomarkers in Alzheimer’s
Gepubliceerd: 12-12-2022 -
Axel Petzold on the diagnosis and classification of optic neuritis
Gepubliceerd: 16-11-2022 -
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery
Gepubliceerd: 18-10-2022 -
Jerome Siegel on sleep habits
Gepubliceerd: 14-9-2022 -
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy
Gepubliceerd: 10-8-2022 -
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
Gepubliceerd: 13-7-2022 -
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies
Gepubliceerd: 15-6-2022 -
Mark Hallett on functional neurological disorder
Gepubliceerd: 13-5-2022 -
Eva Feldman on advances in understanding ALS
Gepubliceerd: 13-4-2022 -
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's
Gepubliceerd: 6-4-2022 -
John Collinge on a treatment for CJD
Gepubliceerd: 16-3-2022 -
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
Gepubliceerd: 22-2-2022
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.
